Banque Pictet & Cie Sa Repligen Corp Transaction History

Banque Pictet & Cie Sa

$14.9 Billion
Q4 2024

A detailed history of Banque Pictet & Cie Sa transactions in Repligen Corp stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 22,392 shares of RGEN stock, worth $3.38 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

22,392

Previous 24,453 8.43%

Holding current value

$3.38 Million

Previous $3.64 Million 11.43%

% of portfolio

0.02%

Previous 0.03%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$123.41 - $160.92 $254,348 - $331,656	-2,061 Reduced 8.43%	22,392 $3.22 Million
Q3 2024 Oct 21, 2024	SELL	$119.79 - $167.35 $1.21 Million - $1.68 Million	-10,062 Reduced 29.15%	24,453 $3.64 Million
Q2 2024 Jul 25, 2024	BUY	$120.0 - $182.95 $1.77 Million - $2.7 Million	14,746 Added 74.59%	34,515 $4.35 Million
Q1 2024 May 06, 2024	SELL	$170.78 - $208.42 $3.74 Million - $4.57 Million	-21,922 Reduced 52.58%	19,769 $3.64 Million
Q4 2023 Feb 09, 2024	BUY	$114.17 - $185.35 $1.2 Million - $1.95 Million	10,538 Added 33.83%	41,691 $7.5 Million
Q3 2023 Nov 02, 2023	BUY	$138.78 - $176.51 $1.56 Million - $1.99 Million	11,247 Added 56.5%	31,153 $4.95 Million
Q2 2023 Aug 04, 2023	SELL	$138.42 - $180.31 $1.81 Million - $2.35 Million	-13,044 Reduced 39.59%	19,906 $2.82 Million
Q1 2023 May 01, 2023	SELL	$154.26 - $198.1 $374,080 - $480,392	-2,425 Reduced 6.86%	32,950 $5.55 Million
Q4 2022 Feb 06, 2023	BUY	$162.42 - $220.56 $983,290 - $1.34 Million	6,054 Added 20.65%	35,375 $0
Q3 2022 Nov 10, 2022	BUY	$160.42 - $256.21 $376,986 - $602,093	2,350 Added 8.71%	29,321 $5.49 Billion
Q2 2022 Aug 08, 2022	BUY	$140.68 - $188.02 $3.79 Million - $5.07 Million	26,971 New	26,971 $4.38 Million

Others Institutions Holding RGEN

# of Institutions

481

Shares Held

56.3M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.36B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Repligen Corp Transaction History